Some Scientific and Organizational Challenges in Cancer Immunology.
Saved in:
| Title: | Some Scientific and Organizational Challenges in Cancer Immunology. |
|---|---|
| Authors: | Steinman, Ralph M.1 (AUTHOR) |
| Source: | Annals of the New York Academy of Sciences. Sep2009, Vol. 1174, p1-5. 5p. |
| Subjects: | Work sampling, Immunology, Cancer patients, Vaccination, Preventive medicine |
| Abstract: | This volume provides a small sampling of the rapidly growing science of cancer immunology. Growth in the field includes advances on the requirements for immunization or vaccination and the ways in which immunity can be suppressed or blocked, including active tumor-based mechanisms. I would like to introduce the papers in this volume and then deal with a subject that pervaded many discussions among symposium participants. The subject is the need for a much better supported and organized effort to design optimal studies of immunology in cancer patients so that cancer vaccines can become a major means to prevent and treat this disease. [ABSTRACT FROM AUTHOR] |
| Copyright of Annals of the New York Academy of Sciences is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | This volume provides a small sampling of the rapidly growing science of cancer immunology. Growth in the field includes advances on the requirements for immunization or vaccination and the ways in which immunity can be suppressed or blocked, including active tumor-based mechanisms. I would like to introduce the papers in this volume and then deal with a subject that pervaded many discussions among symposium participants. The subject is the need for a much better supported and organized effort to design optimal studies of immunology in cancer patients so that cancer vaccines can become a major means to prevent and treat this disease. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00778923 |
| DOI: | 10.1111/j.1749-6632.2009.05060.x |
